Fu J - Search Results

1

Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cells.

Fu J, Koul D, Yao J, Wang S, Yuan Y, Colman H, Sulman EP, Lang FF, Yung WK. Fu J, et al. Cancer Res. 2013 May 15;73(10):3062-74. doi: 10.1158/0008-5472.CAN-12-2033. Epub 2013 Mar 14. Cancer Res. 2013. Retraction in: Cancer Res. 2014 Nov 15;74(22):6731-2. doi: 10.1158/0008-5472.CAN-14-2966. PMID: 23492364 Free PMC article. Retracted.

2

A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.

Saito N, Fu J, Zheng S, Yao J, Wang S, Liu DD, Yuan Y, Sulman EP, Lang FF, Colman H, Verhaak RG, Yung WK, Koul D. Saito N, et al. Among authors: fu j. Stem Cells. 2014 Jan;32(1):301-12. doi: 10.1002/stem.1528. Stem Cells. 2014. PMID: 24038660 Free PMC article.

3

Antitumor activity of NVP-BKM120--a selective pan class I PI3 kinase inhibitor showed differential forms of cell death based on p53 status of glioma cells.

Koul D, Fu J, Shen R, LaFortune TA, Wang S, Tiao N, Kim YW, Liu JL, Ramnarian D, Yuan Y, Garcia-Echevrria C, Maira SM, Yung WK. Koul D, et al. Among authors: fu j. Clin Cancer Res. 2012 Jan 1;18(1):184-95. doi: 10.1158/1078-0432.CCR-11-1558. Epub 2011 Nov 7. Clin Cancer Res. 2012. PMID: 22065080 Free PMC article.

4

A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival.

Zheng S, Fu J, Vegesna R, Mao Y, Heathcock LE, Torres-Garcia W, Ezhilarasan R, Wang S, McKenna A, Chin L, Brennan CW, Yung WK, Weinstein JN, Aldape KD, Sulman EP, Chen K, Koul D, Verhaak RG. Zheng S, et al. Among authors: fu j. Genes Dev. 2013 Jul 1;27(13):1462-72. doi: 10.1101/gad.213686.113. Epub 2013 Jun 24. Genes Dev. 2013. PMID: 23796897 Free PMC article.

5

Overexpression of IL-7 enhances cisplatin resistance in glioma.

Cui L, Fu J, Pang JC, Qiu ZK, Liu XM, Chen FR, Shi HL, Ng HK, Chen ZP. Cui L, et al. Among authors: fu j. Cancer Biol Ther. 2012 May;13(7):496-503. doi: 10.4161/cbt.19592. Epub 2012 May 1. Cancer Biol Ther. 2012. PMID: 22415136 Free PMC article.

6

TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells.

Fu J, Yang QY, Sai K, Chen FR, Pang JC, Ng HK, Kwan AL, Chen ZP. Fu J, et al. Neuro Oncol. 2013 Oct;15(10):1353-65. doi: 10.1093/neuonc/not079. Epub 2013 Jul 21. Neuro Oncol. 2013. PMID: 23877317 Free PMC article.

7

Niban apoptosis regulator 1 promotes gemcitabine resistance by activating the focal adhesion kinase signaling pathway in bladder cancer.

Tong S, Yin H, Fu J, Li Y. Tong S, et al. Among authors: fu j. J Cancer. 2022 Jan 9;13(4):1103-1118. doi: 10.7150/jca.66248. eCollection 2022. J Cancer. 2022. PMID: 35281857 Free PMC article.

8

PTK7 regulates Id1 expression in CD44-high glioma cells.

Liu Q, Zhang C, Yuan J, Fu J, Wu M, Su J, Wang X, Yuan X, Jiang W. Liu Q, et al. Among authors: fu j. Neuro Oncol. 2015 Apr;17(4):505-15. doi: 10.1093/neuonc/nou227. Epub 2014 Sep 8. Neuro Oncol. 2015. PMID: 25204555 Free PMC article.

9

Growth and differentiation factor 15 regulates PD-L1 expression in glioblastoma.

Peng H, Li Z, Fu J, Zhou R. Peng H, et al. Among authors: fu j. Cancer Manag Res. 2019 Apr 2;11:2653-2661. doi: 10.2147/CMAR.S192095. eCollection 2019. Cancer Manag Res. 2019. PMID: 31114328 Free PMC article.

10

Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines.

Fu J, Shao CJ, Chen FR, Ng HK, Chen ZP. Fu J, et al. Neuro Oncol. 2010 Apr;12(4):328-40. doi: 10.1093/neuonc/nop005. Epub 2009 Oct 15. Neuro Oncol. 2010. PMID: 20308311 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,857 results

Search Page

Filters